Lemos C A A, Mello C C, dos Santos D M, Verri F R, Goiato M C, Pellizzer E P
Department of Dental Materials and Prosthodontics, Araçatuba Dental School, UNESP - Universidade Estadual Paulista, Araçatuba, Brazil.
Department of Dental Materials and Prosthodontics, Araçatuba Dental School, UNESP - Universidade Estadual Paulista, Araçatuba, Brazil.
Int J Oral Maxillofac Surg. 2016 Apr;45(4):517-25. doi: 10.1016/j.ijom.2015.07.012. Epub 2016 Jan 6.
This systematic review evaluated the effect on bone formation and implant survival of combining platelet-rich plasma (PRP) with bone grafts in maxillary augmentation. A comprehensive review of articles listed in the PubMed/MEDLINE, Embase, and Cochrane Library databases covering the period January 2000 to January 2015 was performed. The meta-analysis was based on bone formation for which the mean difference (MD, in millimetres) was calculated. Implant survival was assessed as a dichotomous outcome and evaluated using the risk ratio (RR) with 95% confidence interval (CI). The search identified 3303 references. After inclusion and exclusion criteria were applied, 17 studies were selected for qualitative analysis and 13 for quantitative analysis. A total of 369 patients (mean age 51.67 years) and 621 maxillary sinus augmentations were evaluated. After the data analysis, additional analyses were performed of the implant stability quotient, marginal bone loss, and alveolar bone height measured by MD. The results showed no significant difference in implant stability (P=0.32, MD 1.00, 95% CI -0.98 to 2.98), marginal bone loss (P=0.31, MD 0.06, 95% CI -0.05 to 0.16), alveolar bone height (P=0.10, MD -0.72, 95% CI -1.59 to 0.14), implant survival (P=0.22, RR 1.95, 95% CI 0.67-5.69), or bone formation (P=0.81, MD -0.63, 95% CI -5.91 to 4.65). In conclusion, the meta-analysis indicates no influence of PRP with bone graft on bone formation and implant survival in maxillary sinus augmentation.
本系统评价评估了富血小板血浆(PRP)与骨移植材料联合用于上颌窦提升术中对骨形成和种植体存留率的影响。对2000年1月至2015年1月期间PubMed/MEDLINE、Embase和Cochrane图书馆数据库中列出的文章进行了全面检索。荟萃分析基于计算平均差(MD,单位为毫米)的骨形成情况。种植体存留率作为二分结局进行评估,并使用风险比(RR)及95%置信区间(CI)进行评价。检索共识别出3303篇参考文献。应用纳入和排除标准后,选择了17项研究进行定性分析,13项进行定量分析。共评估了369例患者(平均年龄51.67岁)和621例上颌窦提升术。数据分析后,对通过MD测量的种植体稳定性商数、边缘骨丢失和牙槽骨高度进行了额外分析。结果显示,在种植体稳定性(P = 0.32,MD 1.00,95% CI -0.98至2.98)、边缘骨丢失(P = 0.31,MD 0.06,95% CI -0.05至0.16)、牙槽骨高度(P = 0.10,MD -0.72,95% CI -1.59至0.14)、种植体存留率(P = 0.22,RR 1.95,95% CI 0.67 - 5.69)或骨形成(P = 0.81,MD -0.63,95% CI -5.91至4.65)方面均无显著差异。总之,荟萃分析表明PRP与骨移植材料联合应用对上颌窦提升术中的骨形成和种植体存留率无影响。